HIV, Gilead and PrEP
Glenda Gray, program director of a research consortium, talked with STAT about the impact of the funding freeze on an HIV ...
AllAfrica on MSN1d
U.S. Funding Cuts Imperil Search for HIV Vaccine [blog]A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in funding from the United States government. As a result, several promising ...
A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people ...
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...
An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...
Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.
This research on a T-cell–targeting vaccines in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of ...
5h
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who struggle to take daily HIV pills may benefit from long-acting injectable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback